$2.04+0.10 (+5.15%)
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
Clarivate Plc in the Technology sector is trading at $2.04 with a market capitalization of $1.7B. Wall Street consensus targets $2.50 (2 analysts), implying a +22.5% move over the next 12 months. The stock is currently near its 52-week low of $1.66, remaining 26.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $585.50M↓ | $617.00M↓ | $623.10M↑ | $621.40M↑ | $593.70M |
| Gross Profit | $393.40M↓ | $412.20M↑ | $404.90M↓ | $417.80M↑ | $386.70M |
| Operating Income | $29.60M↓ | $58.00M↑ | $40.60M↓ | $48.90M↑ | $24.60M |
| Net Income | -$40.20M↓ | $3.10M↑ | -$28.30M↑ | -$72.00M↑ | -$103.90M |
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers s...
Clarivate Plc announced that France’s Bibliographic Agency for Higher Education (Abes) has selected its Alma, Primo and Rapido platforms, under a multi-year agreement, to modernize the national academic library system that underpins more than 15 million records across 3,000 libraries. The Abes decision highlights how Clarivate’s cloud-based, AI-enabled library and discovery tools are becoming embedded in critical national research infrastructure, extending its role in France’s higher...
Clarivate (CLVT) stock is in focus after the company was chosen by France’s Bibliographic Agency for Higher Education, Abes, to modernize the country’s national academic library system under a multi-year agreement. See our latest analysis for Clarivate. The Abes agreement lands at a time when Clarivate’s share price has been volatile, with a 1-month share price return of 4.98%, a year-to-date share price decline of 28.40%, and a 1-year total shareholder return that is down 44.36%. This...
Clarivate PLC (NYSE:CLVT) is one of the 15 best NYSE penny stocks to buy according to hedge funds. On July 6, Clarivate PLC (NYSE:CLVT) disclosed that it signed a definitive agreement to sell its Life Sciences & Healthcare segment to Altaris for a consideration of around $600 million. Upon completion of this divestment, the company […]
Clarivate (NYSE:CLVT) said it has reached an agreement to sell substantially all of its Life Sciences & Healthcare segment to Altaris, an investment firm focused on the healthcare industry, in a transaction valued at $600 million. Chief Executive Officer Matti Shem Tov said on a conference call
Clarivate (NYSE:CLVT) is one of the best value penny stocks to buy according to hedge funds. On May 29, Clarivate Plc introduced IPOne, a unified intelligence platform designed to integrate purpose-built AI agents with proprietary data to streamline intellectual property research and workflows. Developed in partnership with corporate IP teams and law firms, the platform […]